178 related articles for article (PubMed ID: 33666857)
21. Chemical complementarity between immune receptor CDR3s and candidate cancer antigens correlating with reduced survival: evidence for outcome mitigation with corticosteroid treatments.
Patel AR; Patel DN; Tu YN; Yeagley M; Chobrutskiy A; Chobrutskiy BI; Blanck G
J Biomol Struct Dyn; 2023 Jul; 41(10):4632-4640. PubMed ID: 35538689
[TBL] [Abstract][Full Text] [Related]
22. Distinct signatures of the immune responses in low risk versus high risk neuroblastoma.
Gowda M; Godder K; Kmieciak M; Worschech A; Ascierto ML; Wang E; Marincola FM; Manjili MH
J Transl Med; 2011 Oct; 9():170. PubMed ID: 21978632
[TBL] [Abstract][Full Text] [Related]
23. Immunogenomics of colorectal adenocarcinoma: Survival distinctions represented by immune receptor, CDR3 chemical features and high expression of BTN gene family members.
Diaz MJ; Chobrutskiy BI; Zaman S; Blanck G
Cancer Treat Res Commun; 2020; 24():100196. PubMed ID: 32769037
[TBL] [Abstract][Full Text] [Related]
24. Recovery of T-cell receptor V(D)J recombination reads from lower grade glioma exome files correlates with reduced survival and advanced cancer grade.
Chobrutskiy BI; Zaman S; Tong WL; Diviney A; Blanck G
J Neurooncol; 2018 Dec; 140(3):697-704. PubMed ID: 30382482
[TBL] [Abstract][Full Text] [Related]
25. Electrostatic Complementarities of Glioblastoma-Resident T-Cell Receptors and Cancer Testis Antigens Linked to Poor Outcomes and High Levels of Sphingosine Kinase-2 Expression.
Arias MA; Cios KJ; Kacsoh DB; Montgomery BE; Song JJ; Patel AR; Chobrutskiy A; Chobrutskiy BI; Blanck G
Biology (Basel); 2023 Apr; 12(4):. PubMed ID: 37106775
[TBL] [Abstract][Full Text] [Related]
26. Immunocombination therapy for high-risk neuroblastoma.
Kroesen M; Lindau D; Hoogerbrugge P; Adema GJ
Immunotherapy; 2012 Feb; 4(2):163-74. PubMed ID: 22394368
[TBL] [Abstract][Full Text] [Related]
27. Chemical features of blood-borne TRG CDR3s associated with an increased overall survival in breast cancer.
Chobrutskiy A; Chobrutskiy BI; Zaman S; Hsiang M; Blanck G
Breast Cancer Res Treat; 2021 Feb; 185(3):591-600. PubMed ID: 33180235
[TBL] [Abstract][Full Text] [Related]
28. Clonally expanded γδ T cells protect against Staphylococcus aureus skin reinfection.
Dillen CA; Pinsker BL; Marusina AI; Merleev AA; Farber ON; Liu H; Archer NK; Lee DB; Wang Y; Ortines RV; Lee SK; Marchitto MC; Cai SS; Ashbaugh AG; May LS; Holland SM; Freeman AF; Miller LG; Yeaman MR; Simon SI; Milner JD; Maverakis E; Miller LS
J Clin Invest; 2018 Mar; 128(3):1026-1042. PubMed ID: 29400698
[TBL] [Abstract][Full Text] [Related]
29. Next-Generation Sequencing Analysis of the Human TCRγδ+ T-Cell Repertoire Reveals Shifts in Vγ- and Vδ-Usage in Memory Populations upon Aging.
Kallemeijn MJ; Kavelaars FG; van der Klift MY; Wolvers-Tettero ILM; Valk PJM; van Dongen JJM; Langerak AW
Front Immunol; 2018; 9():448. PubMed ID: 29559980
[TBL] [Abstract][Full Text] [Related]
30. Lysis of MYCN-amplified neuroblastoma cells by MYCN peptide-specific cytotoxic T lymphocytes.
Sarkar AK; Nuchtern JG
Cancer Res; 2000 Apr; 60(7):1908-13. PubMed ID: 10766179
[TBL] [Abstract][Full Text] [Related]
31. Chemical features of melanoma tumor resident TRG CDR3s associated with better survival probabilities.
Agnila DRL; Huda TI; Eakins RA; Patel DN; Hsiang M; Chobrutskiy A; Chobrutskiy BI; Blanck G
Melanoma Res; 2023 Aug; 33(4):275-282. PubMed ID: 37222076
[TBL] [Abstract][Full Text] [Related]
32. T-cell receptor repertoire in neuroblastoma patients.
Valteau D; Scott V; Carcelain G; Hartmann O; Escudier B; Hercend T; Triebel F
Cancer Res; 1996 Jan; 56(2):362-9. PubMed ID: 8542593
[TBL] [Abstract][Full Text] [Related]
33. Immune receptor repertoires in pediatric and adult acute myeloid leukemia.
Zhang J; Hu X; Wang J; Sahu AD; Cohen D; Song L; Ouyang Z; Fan J; Wang B; Fu J; Gu S; Sade-Feldman M; Hacohen N; Li W; Ying X; Li B; Liu XS
Genome Med; 2019 Nov; 11(1):73. PubMed ID: 31771646
[TBL] [Abstract][Full Text] [Related]
34. Immunogenomics: A Negative Prostate Cancer Outcome Associated with TcR-γ/δ Recombinations.
Tu YN; Tong WL; Yavorski JM; Blanck G
Cancer Microenviron; 2018 Jun; 11(1):41-49. PubMed ID: 29357011
[TBL] [Abstract][Full Text] [Related]
35. IGH Complementarity Determining Region-3-Cytomegalovirus Protein Chemical Complementarity Linked to Better Overall Survival Probabilities for Glioblastoma.
Hudock TR; Song JJ; Chobrutskiy A; Chobrutskiy BI; Blanck G
Viral Immunol; 2024 Jun; ():. PubMed ID: 38848306
[TBL] [Abstract][Full Text] [Related]
36. A transplantable TH-MYCN transgenic tumor model in C57Bl/6 mice for preclinical immunological studies in neuroblastoma.
Kroesen M; Nierkens S; Ansems M; Wassink M; Orentas RJ; Boon L; den Brok MH; Hoogerbrugge PM; Adema GJ
Int J Cancer; 2014 Mar; 134(6):1335-45. PubMed ID: 24038106
[TBL] [Abstract][Full Text] [Related]
37. An immunoinformatics assessment of the cancer testis antigen, DDX53, as a potential early esophageal cancer antigen.
Cheng P; Cios KJ; Varkhedi M; Barker VR; Yeagley M; Chobrutskiy A; Chobrutskiy BI; Blanck G
Oncoscience; 2023; 10():59-66. PubMed ID: 37953875
[TBL] [Abstract][Full Text] [Related]
38. T-cell receptor-α CDR3 domain chemical features correlate with survival rates in bladder cancer.
Chobrutskiy BI; Zaman S; Diviney A; Mihyu MM; Blanck G
J Cancer Res Clin Oncol; 2019 Mar; 145(3):615-623. PubMed ID: 30539280
[TBL] [Abstract][Full Text] [Related]
39. PD-L1 checkpoint inhibition and anti-CTLA-4 whole tumor cell vaccination counter adaptive immune resistance: A mouse neuroblastoma model that mimics human disease.
Srinivasan P; Wu X; Basu M; Rossi C; Sandler AD
PLoS Med; 2018 Jan; 15(1):e1002497. PubMed ID: 29377881
[TBL] [Abstract][Full Text] [Related]
40. Assessing microenvironment immunogenicity using tumor specimen exomes: Co-detection of TcR-α/β V(D)J recombinations correlates with PD-1 expression.
Tu YN; Tong WL; Samy MD; Yavorski JM; Kim M; Blanck G
Int J Cancer; 2017 Jun; 140(11):2568-2576. PubMed ID: 28256716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
